Liver
Matters
Help us push the frontiers of liver research across rare and chronic liver diseases by bringing together a pre-competitive consortium of pharma collaborators
to create a geographically diverse liver-focused registry across North America and Europe.
Sub-Study
Ready
Configuration is part of our DNA. To support sub-studies of interest to sponsors, the core platform is natively built to be configured with ease with the depth of study workflow and the user experience demanded by modern consumers.
- Tailor look and feel for the sub-study
- Add consent or assent workflows
- Collect additional data elements (ePROs, eCOAs, eCRFs)
- Clinically validate patient-reported data remotley
- Add & manage file uploads
- Ingest & harmonize retrospective data
- Configure adverse event triggers & notifications
- Integrate real-world and randomized control trial data via advanced modeling
We enable evidence generation throughout the lifecycle of a molecule
- Natural History Data
- Deepen relationships with expert researcher
- Inform pipeline prioritization
- Inform trial design
- Develop clinical endpoints
- Define and create comparator arms
- Capture QoL data
- External control arms
- Market Access studies
- Reimbursement & Payor evidence
- Long-Term Follow-Up
- Safety and REMS studies
A Robust Foundation of Real-World Data
By launching with ePROs and providing optionality to expand clinical, phenotypic and biomarker data, we offer sponsors a pragmatic platform to augment research, understanding of disease, clinical trial performance, and treatment effectiveness.
Decentralized model
Social listening capabilities to further refine insights gathered remotley.
Hepatic Common Data Elements (CDEs) across conditions
Disease-specific data Elements, including PBC and MASH. Omics data also supported.
Seamless Study Expansion
The Pulse Platform framework supports adding sub-studies and additional sites alongside ongoing remote data collection. (eCOAs, eCRFs)
